Sigma-Aldrich Q4 Revenues Increase 4 Percent, Beat Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that revenues for its fourth quarter rose 4 percent year over year as the firm beat the consensus analyst estimate on the top and bottom lines.

Total revenues for the three months ended Dec. 31, 2013 reached $684 million, up from $655 million a year ago and above the average analyst estimate of $676 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.